According to a recent report, the global data privacy software market size is estimated to grow at 36% CAGR to reach $17.2 billion market by 2032 from $3.84 billion in 2024. The significant growth in the industry is expected to be driven by the continuing adoption of IoT devices along with the added power of
Lexington-based Valo Health is one of the pioneering players in the AI-drug discovery market. Set up in 2019 as part of Flagship Pioneering’s initiatives, Valo has had quite a roller coaster ride so far.
The Small Molecule Drug Discovery Market is estimated to grow at 9% CAGR from $74.08 billion in 2024 to reach $175.41 billion by 2034. San Francisco-based Atomwise is one player that is making use of its AI capabilities to make a mark in the industry.
Communication Platform as a Service (CPaaS) player Twilio (NYSE: TWLO) recently announced its third quarter results that outpaced market expectations. The improved outlook and the strong performance helped take the stock 10% higher in the after-hours trading session.
Amazon (NASDAQ: AMZN) recently announced its third-quarter results that beat market expectations driven by its growth in its cloud and advertising businesses.
NVIDIA (NASDAQ: NVDA) last week reported its second quarter results which beat all estimates. However, after three straight quarters of revenue growth above 200%, its growth of 122% seems a tad disappointing and its shares fell 8% in extended trading. This is a slight pullback after an astronomical rally following the AI boom. Its stock
Communication Platform as a Service (CPaaS) player Twilio (NYSE: TWLO) recently announced its second quarter results that outpaced market expectations. The impressive outlook for the coming quarters sent the stock soaring 7% in the after-hours trading session.
Earlier this month, Apple (Nasdaq: AAPL) announced its third quarter results that continued to outpace market expectations. Despite declining iPhone sales, Apple saw significant upside in its other businesses as it continues to push forward on its AI-focused journey.